Scientists investigated the efficacy of human MSCs in high vs low human macrophage migration inhibitory factor (hMIF) environments and the impact of MIF pre-licensing of MSCs using humanized MIF mice in a clinically relevant house dust mite model of allergic asthma.
[Molecular Therapy]